Return On Equity of HTG MOLECULAR DIAGNOSTICS, INC from 30 Sep 2015 to 31 Mar 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
HTG MOLECULAR DIAGNOSTICS, INC quarterly and annual Return On Equity in % history and change rate from 30 Sep 2015 to 31 Mar 2023.
  • HTG MOLECULAR DIAGNOSTICS, INC Return On Equity for the quarter ending 31 Mar 2023 was -638%, a 366% decline year-over-year.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Return On Equity for 2022 was -369%, a 225% decline from 2021.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Return On Equity for 2021 was -113%, a 3.3% increase from 2020.
  • HTG MOLECULAR DIAGNOSTICS, INC annual Return On Equity for 2020 was -117%, a 21% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

HTG MOLECULAR DIAGNOSTICS, INC Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2023 -638% -501% -366% 01 Jan 2023 31 Mar 2023
Q4 2022 -369% -255% -225% 01 Oct 2022 31 Dec 2022
Q3 2022 -311% -210% -209% 01 Jul 2022 30 Sep 2022
Q2 2022 -210% -105% -101% 01 Apr 2022 30 Jun 2022
Q1 2022 -137% -14% -12% 01 Jan 2022 31 Mar 2022
Q4 2021 -113% +3.9% +3.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -100% +3.4% +3.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -104% -16% -19% 01 Apr 2021 30 Jun 2021
Q1 2021 -122% -32% -35% 01 Jan 2021 31 Mar 2021
Q4 2020 -117% -20% -21% 01 Oct 2020 31 Dec 2020
Q3 2020 -104% -15% -17% 01 Jul 2020 30 Sep 2020
Q2 2020 -88% +8.2% +8.5% 01 Apr 2020 30 Jun 2020
Q1 2020 -91% -15% -20% 01 Jan 2020 31 Mar 2020
Q4 2019 -97% -32% -50% 01 Oct 2019 31 Dec 2019
Q3 2019 -89% -5.2% -6.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -96% +37% +28% 01 Apr 2019 30 Jun 2019
Q1 2019 -76% +264% +78% 01 Jan 2019 31 Mar 2019
Q4 2018 -64% -442% -117% 01 Oct 2018 31 Dec 2018
Q3 2018 -83% -485% -121% 01 Jul 2018 30 Sep 2018
Q2 2018 -133% -602% -128% 01 Apr 2018 30 Jun 2018
Q1 2018 -339% -1012% -150% 01 Jan 2018 31 Mar 2018
Q4 2017 378% +1915% 01 Oct 2017 31 Dec 2017
Q3 2017 402% +758% 01 Jul 2017 30 Sep 2017
Q2 2017 469% +652% 01 Apr 2017 30 Jun 2017
Q1 2017 673% +799% 01 Jan 2017 31 Mar 2017
Q4 2016 -1538% -2639% -240% 01 Oct 2016 31 Dec 2016
Q3 2016 -356% -440% -524% 01 Jul 2016 30 Sep 2016
Q2 2016 -184% 01 Apr 2016 30 Jun 2016
Q1 2016 -126% 01 Jan 2016 31 Mar 2016
Q4 2015 1102% 01 Oct 2015 31 Dec 2015
Q3 2015 84% 01 Jul 2015 30 Sep 2015

HTG MOLECULAR DIAGNOSTICS, INC Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2022 -369% -255% -225% 01 Jan 2022 31 Dec 2022
2021 -113% +3.9% +3.3% 01 Jan 2021 31 Dec 2021
2020 -117% -20% -21% 01 Jan 2020 31 Dec 2020
2019 -97% -32% -50% 01 Jan 2019 31 Dec 2019
2018 -64% -442% -117% 01 Jan 2018 31 Dec 2018
2017 378% +1915% 01 Jan 2017 31 Dec 2017
2016 -1538% -2639% -240% 01 Jan 2016 31 Dec 2016
2015 1102% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.